COMPREHENSIVE ANTIBIOGRAM for Henderson all clinical areas

January 1 to June 30, 2006

% SUSCEPTIBLE

# Isolates / Amikacin / Ampicillin / Azithromycin / Beta lactamase / Cefazolin / Cefotaxime / Ceftazidime / Ciprofloxacin / Clindamycin / Gentamicin
synergy* / Levofloxacin / Meropenem / Oxacillin / Penicillin-G / Piperacillin / Piperacillin
/tazobac / Streptomycin
synergy* / Tetracycline / Tobramycin / Trimethprim/Sulfa / Vancomycin
GRAM POSITIVE
Enterococcus faecalis / 28 / 100 / 50 / 100* / 89 / 100 / 18 / 100
Enterococcus faecium / 10 / 20 / 11 / 100* / 11 / 100 / 100 / 100
Enterococcus group D / 113 / 93 / 45 / 100* / 88 / 100 / 24 / 100
Staphylococcus aureus (including MRSA) / 192 / 16 / 77 / 72 / 62 / 97 / 77 / 96 / 97 / 100

MRSA

/ 43 / 0 / 0 / 0 / 0 / 98 / 0 / 98 / 95 / 100

Streptococcus pneumoniae

/ 21 / 100 / 100 / 100 / 58 / 100 / 91 / 100
GRAM NEGATIVE
Escherichiae coli / 422 / 67 / 92 / 99 / 97 / 85 / 91 / 100 / 73 / 98 / 92 / 82
Klebsiella pneumoniae / 84 / 98 / 0 / 88 / 98 / 98 / 95 / 98 / 100 / 88 / 96 / 98 / 97
Pseudomonas aeruginosa / 102 / 99 / 92 / 74 / 88 / 95 / 98 / 97 / 99
MR Pseudo. aeruginosa / 15 / 100 / 7 / 7 / 47 / 40 / 7 / 13 / 67

* Percentage of organisms with synergistic bactericidal activity with gentamicin/streptomycin when combined with penicillin/vancomycin.

++ These organisms may produce inducible ß-lactams Use of ß-lactams may result in clinical failure despite in vitro susceptibility.